- Home
- STRO vs SMLR Comparison
STRO vs SMLR Comparison
Compare STRO & SMLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- SMLR
- Stock Information
- Founded
- STRO 2003
- SMLR 2007
- Country
- STRO United States
- SMLR United States
- Employees
- STRO N/A
- SMLR N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- SMLR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- STRO Health Care
- SMLR Health Care
- Exchange
- STRO Nasdaq
- SMLR Nasdaq
- Market Cap
- STRO 292.6M
- SMLR 289.5M
- IPO Year
- STRO 2018
- SMLR 2014
- Fundamental
- Price
- STRO $2.84
- SMLR $61.75
- Analyst Decision
- STRO Strong Buy
- SMLR
- Analyst Count
- STRO 7
- SMLR 0
- Target Price
- STRO $12.14
- SMLR N/A
- AVG Volume (30 Days)
- STRO 1.0M
- SMLR 1.1M
- Earning Date
- STRO 11-13-2024
- SMLR 11-04-2024
- Dividend Yield
- STRO N/A
- SMLR N/A
- EPS Growth
- STRO N/A
- SMLR N/A
- EPS
- STRO N/A
- SMLR 2.04
- Revenue
- STRO $160,955,000.00
- SMLR $58,938,000.00
- Revenue This Year
- STRO N/A
- SMLR N/A
- Revenue Next Year
- STRO N/A
- SMLR N/A
- P/E Ratio
- STRO N/A
- SMLR $28.73
- Revenue Growth
- STRO 230.90
- SMLR N/A
- 52 Week Low
- STRO $2.45
- SMLR $20.88
- 52 Week High
- STRO $6.13
- SMLR $79.45
- Technical
- Relative Strength Index (RSI)
- STRO 41.69
- SMLR 61.11
- Support Level
- STRO $2.66
- SMLR $57.33
- Resistance Level
- STRO $2.86
- SMLR $69.67
- Average True Range (ATR)
- STRO 0.19
- SMLR 9.09
- MACD
- STRO 0.02
- SMLR -0.32
- Stochastic Oscillator
- STRO 78.00
- SMLR 51.22
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About SMLR Semler Scientific Inc.
Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.